Screener
Eikon Therapeutics, Inc. EIKN Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Eikon Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The source filing: Eikon Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216791
| Year Ending December 31, | |
|---|---|
| 2029 | 36,777 |
| 2030 | 35,913 |
| Thereafter | 370,302 |
| Total future minimum lease payments | 551,576 |
| Less: Imputed interest | (296,745) |
| Present value of future lease payments | 254,831 |
| Less: Operating lease liability, current | (9,740) |
| Operating lease liability, net of current portion | $245,091 |
Item 1. Condensed Financial Statements (Unaudited).
FAQ
- What is Eikon Therapeutics, Inc.'s operating lease liabilities (total)?
- Eikon Therapeutics, Inc. (EIKN) reported operating lease liabilities (total) of $254.83M in Q1 2026.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.
Ask your AI about Eikon Therapeutics, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude